- Report
- May 2025
- 196 Pages
Global
From €3203EUR$3,545USD£2,739GBP
€3559EUR$3,939USD£3,043GBP
- Report
- June 2025
- 168 Pages
Global
From €5286EUR$5,850USD£4,519GBP
- Report
- April 2025
- 200 Pages
Global
From €4057EUR$4,490USD£3,468GBP
- Report
- March 2024
- 180 Pages
Global
From €5376EUR$5,950USD£4,596GBP
- Report
- February 2024
- 182 Pages
Global
From €3456EUR$3,825USD£2,955GBP
€4066EUR$4,500USD£3,476GBP
- Report
- February 2024
- 132 Pages
Global
From €4292EUR$4,750USD£3,669GBP
- Report
- April 2024
- 124 Pages
Global
From €2855EUR$3,160USD£2,441GBP
€3569EUR$3,950USD£3,051GBP
- Report
- October 2023
- 146 Pages
Global
From €3750EUR$4,150USD£3,206GBP
- Report
- October 2024
Global
From €3162EUR$3,500USD£2,704GBP
The Thyroid Stimulating Hormone (TSH) Test is a type of In Vitro Diagnostics (IVD) used to measure the amount of TSH in a patient's blood. TSH is a hormone produced by the pituitary gland that stimulates the thyroid gland to produce hormones that regulate metabolism. The TSH Test is used to diagnose and monitor thyroid disorders, such as hypothyroidism and hyperthyroidism. It is also used to monitor the effectiveness of thyroid hormone replacement therapy.
The TSH Test market is a subset of the larger IVD market, which is estimated to be worth billions of dollars. The TSH Test market is expected to grow at a steady rate due to the increasing prevalence of thyroid disorders and the need for accurate diagnosis and monitoring.
Some companies in the TSH Test market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more
